- 2025-05-20 09:53SMARCA2-IN-1 2568055-21-8
- 2025-05-20 09:53CSV0C018875 hydrochloride 474084-56-5
- 2025-05-20 09:53(R)-α7 nAchR-JAK2-STAT3 agonist 1
- 2025-05-20 09:53LSD1-IN-22 2821068-05-5
- 2025-05-20 09:53SMARCA2 ligand-12-3-methylazetidine
- 2025-05-20 09:53CSV0C018875 442150-41-6
- 2025-05-20 09:53(R)-9b 1655527-68-6
- 2025-05-20 09:53KDOAM-25 trihydrochloride
- 2025-05-20 09:53SMARCA2 degrader-17 2755761-78-3
- 2025-05-20 09:53CPI-169 1450655-76-1
- 2025-05-20 09:52(3S,4S)-Tofacitinib 1092578-47-6
- 2025-05-20 09:52SJH1-51B
- 2025-05-20 09:52CPI-1328 2390367-27-6
- 2025-05-20 09:52KDOAM-25citrate 2448475-08-7
- 2025-05-20 09:52(3S,4R)-Tofacitinib 1092578-48-7
- 2025-05-20 09:52SJ46421
- 2025-05-20 09:52CPI-360 1802175-06-9
- 2025-05-20 09:52KDM5-IN-48 1628210-26-3
- 2025-05-20 09:52(2R,5S)-Ritlecitinib 1792180-79-0
- 2025-05-20 09:52CMP-5 dihydrochloride 2309409-79-6
